Allium coated metal ureteral stent for the treatment of radiation induced ureteral stricture
王明瑞,胡浩,王起,赖金惠,刘献辉,熊杰,许克新,徐涛
DOI: https://doi.org/10.3760/cma.j.cn112330-20200623-00488
2020-01-01
Abstract:Objective:To discuss the efficacy and safety of Allium coated metal ureteral stent in the treatment of radiation induced ureteral stricture (RIUS).Methods:The data of 23 patients (34 sides) with RIUS treated with Allium coated metal ureteral stent from October 2018 to December 2019 in Peking University People's Hospital were retrospectively analyzed, including 1 male (1 side) and 22 female (33 sides). The mean age was (57.4±11.5) years old. The preoperative median serum creatinine was 96.0(47.0-421.0) μmol/L. Unilateral ureteral stricture was observed in 12 cases and bilateral stricture in 11 cases. The average width of the renal pelvis was (2.3±1.1) cm. The primary diseases included cervical cancer (17 cases), rectal cancer (3 cases), endometrial cancer (2 case) and ureteral cancer (1 case). There were 2 cases treated with radical radiotherapy and 21 cases with operation combined with chemoradiotherapy. Preoperative percutaneous nephrostomy tube was observed in 5 cases (7 sides). 18 patients (27 sides) had ureteral stents. Median indwelling time of D-J stent was 18.0 (2.0-84.0) months, replacement every 5.0(1.0-12.0) months, and the total score of the ureteral stent symptom questionnaire (USSQ) 99.0 (59.0-126.0). The location and length of ureteral stricture were measured by retrograde urography. Then ureteral balloon dilatation [2 533.1kPa(25ATM), 3 min]was performed. According to the length of ureteral stricture, 1-3 Allium stents were inserted under X-ray and released after in place, and finally urography was done again to confirm. The serum creatinine, ultrasonography and abdominal X-ray were reviewed in the first day, every 6 months after the operation to evaluate the renal function, location and patency of Allium stent, USSQ were recorded to evaluate quality of life. Postoperative complications were assessed by Clavien-Dindo system.Results:All the 23 cases in this group were successfully operated, with an average operation time of (100.7±37.2) min. Retrograde urography revealed 8 full-length ureteral strictures, 20 cases in the middle and lower segments, 5 in the lower segments and 1 in the middle segments. The mean stenosis length was (15.9±5.9) cm. Three Allium stents unilaterally were placed on 6 sides, 2 stents on 18 sides and 1 stent on 10 sides. The success rate of indwelling is 100%. Compared with preoperative data, serum creatinine was 93.5 (54.0-289.0) μmol/L in 6 months after surgery, significantly lower than that before surgery (
P=0.005), but there was no significant difference in renal pelvis width and USSQ total score. Serum creatinine 89.0 (45.0-342.0) μmol/L, renal pelvis width (1.6±0.6) cm and USSQ total score of 66.0 (50.0-105.0) in the last follow-up after surgery were significantly reduced. Postoperative Clavien-Dindo Ⅰ complications occurred in 3 patients (13.0%), presenting stent related symptoms such as flank and abdominal pain, hematuria and lower urinary tract symptoms, which were all improved after conservative treatment. There were 4 patients (17.4%) with Clavien-Dindo Ⅲ complications, including Allium ureteral stent displacement in 2 cases and stent encrustation in 2 cases. After endoscopic surgery, Allium ureteral stent was removed and D-J stents were inserted in 2 cases due to repeated encrustation. The median follow-up was 16.5 (11.0-24.0) months. Allium ureteral stent was effective in 21 patients (32 sides, 94.1%).
Conclusions:Allium ureteral stent used for the treatment of RIUS could be safe and effective. Patient’s renal function and quality of life could be improved.